We explore the controversy around whether sickle cell carriers are at a higher risk of developing health complications.
In countries such as the Democratic Republic of Congo, the fight against sickle cell disease takes up significant healthcare resources.
The COVID-19 pandemic has brought about a subsection of medical literature exploring the course of various diseases during the viral outbreak.
We review the most recent studies and guidelines on the management of pregnant women with sickle cell disease (SCD).
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Two recently published studies detail the wide-reaching burden of sickle cell disease among patients of all ages.
Oxidative stress plays an important role in the pathophysiology of SCD. Therefore, antioxidant therapies might add value as secondary treatments in SCD.
Neuropathic pain is an understudied, less recognized, and clinically undertreated subcategory of pain in SCD.
The CRISPR/Cas9 system is a versatile and effective system that has been explored in the context of multiple genetic disorders, including SCD.